IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET)

Peer Review reports

Original Submission
8 Sep 2021	Submitted	Original manuscript
20 Dec 2021	Reviewed	Reviewer Report - Riaz Qureshi
20 Jan 2022	Author responded	Author comments - Zahra Nochi
Resubmission - Version 2
20 Jan 2022	Submitted	Manuscript version 2
24 Jan 2022	Reviewed	Reviewer Report - Riaz Qureshi
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
5 Feb 2022	Editorially accepted
19 Feb 2022	Article published	10.1186/s13063-022-06087-1

Back to article page